1. Home
  2. ABR vs OABI Comparison

ABR vs OABI Comparison

Compare ABR & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

N/A

Current Price

$1.27

Market Cap

809.7M

Sector

Real Estate

ML Signal

N/A

Logo OmniAb Inc.

OABI

OmniAb Inc.

N/A

Current Price

$4.92

Market Cap

773.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ABR
OABI
Founded
2003
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
809.7M
773.1M
IPO Year
2003
2021

Fundamental Metrics

Financial Performance
Metric
ABR
OABI
Price
$1.27
$4.92
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$2.25
★ $8.33
AVG Volume (30 Days)
★ 9.1M
1.5M
Earning Date
10-30-2026
10-30-2026
Dividend Yield
★ 72.31%
N/A
EPS Growth
N/A
★ 6.56
EPS
N/A
★ N/A
Revenue
N/A
★ $18,666,000.00
Revenue This Year
N/A
$94.10
Revenue Next Year
N/A
$30.33
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.28
$1.35
52 Week High
$9.30
$5.45

Technical Indicators

Market Signals
Indicator
ABR
OABI
Relative Strength Index (RSI) 14.22 50.07
Support Level N/A $4.43
Resistance Level $5.38 $5.30
Average True Range (ATR) 0.15 0.38
MACD -0.05 -0.03
Stochastic Oscillator 0.28 51.36

Price Performance

Historical Comparison
ABR
OABI

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: